You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Details for New Drug Application (NDA): 203791


✉ Email this page to a colleague

« Back to Dashboard


NDA 203791 describes SITAVIG, which is a drug marketed by Lnhc and is included in one NDA. There are three patents protecting this drug. Additional details are available on the SITAVIG profile page.

The generic ingredient in SITAVIG is acyclovir. There are fifty-six drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the acyclovir profile page.
Summary for 203791
Tradename:SITAVIG
Applicant:Lnhc
Ingredient:acyclovir
Patents:3
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 203791

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;BUCCALStrength50MG
Approval Date:Apr 12, 2013TE:RLD:Yes
Patent:⤷  Try a TrialPatent Expiration:Jun 16, 2030Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF HERPES LABIALIS
Patent:⤷  Try a TrialPatent Expiration:Jun 3, 2027Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF HERPES LABIALIS
Patent:⤷  Try a TrialPatent Expiration:Mar 23, 2027Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF HERPES LABIALIS

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.